CDT Equity CDT
NASDAQ CDT
$0.33 -0.27 (-45.13%)
As of: Sep 10, 2026 · 12:56 PM EDT

CDT Equity (CDT) EBITDA (2022 - 2026)

CDT Equity's (CDT) quarterly EBITDA came in at -$3.0 million in Q2 2026, up 39.38% on a YoY basis from -$2.2 million in Q2 2025, and up 18.86% quarter-over-quarter from -$3.7 million in Q1 2026.

Analysis

CDT Equity (CDT) EBITDA (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has reported EBITDA for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBITDA rose 39.38% year-over-year to -$3.0 million; the trailing twelve-month figure through Jun 2026 stood at -$34.9 million (down 95.25% YoY), and the FY2025 full-year result was -$36.8 million, down 138.67% from the prior year.
  • EBITDA grew to -$3.0 million in Q2 2026 per CDT's latest filing, from -$3.7 million in the prior quarter.
  • Across five years, EBITDA topped out at -$263718.0 in Q1 2022 and bottomed at -$21.2 million in Q4 2025.
  • Historically, EBITDA has averaged -$3.7 million across 5 years, with a median of -$3.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: EBITDA jumped 53.91% in 2023, then plunged 1251.4% in 2024.
  • Over 5 years, EBITDA stood at -$1.7 million in 2022, then tumbled by 47.37% to -$2.5 million in 2023, then slumped by 42.4% to -$3.5 million in 2024, then slumped by 503.44% to -$21.2 million in 2025, then surged by 85.84% to -$3.0 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$3.0 million, -$3.7 million, and -$21.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 640.79 Bn 620.03 Bn 17.26 Bn 7.14 Bn
2 AbbVie 445.95 Bn 439.38 Bn 12.70 Bn 6.43 Bn
3 Merck 357.40 Bn 350.26 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 267.40 Bn 259.71 Bn 11.24 Bn 4.75 Bn
5 Pfizer 156.52 Bn 144.82 Bn 10.94 Bn 4.27 Bn
6 Sanofi 52.15 Bn 44.77 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 43.02 Bn 43.02 Bn - -505.13 Mn
8 Incyte 24.59 Bn 20.06 Bn 1.57 Bn 697.90 Mn
9 United Therapeutics 21.31 Bn 18.64 Bn 683.80 Mn 330.80 Mn
10 CDT Equity 179,140.97 179,140.97 - -3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.00 Mn
Mar 31, 2026 -3.70 Mn
Dec 31, 2025 -21.20 Mn
Sep 30, 2025 -7.03 Mn
Jun 30, 2025 -4.95 Mn
Mar 31, 2025 -3.62 Mn
Dec 31, 2024 -3.51 Mn
Sep 30, 2024 -5.81 Mn
Jun 30, 2024 -3.14 Mn
Mar 31, 2024 -2.96 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -430,000.00
Jun 30, 2023 -888,000.00
Mar 31, 2023 -1.52 Mn
Dec 31, 2022 -1.67 Mn
Sep 30, 2022 -933,000.00
Jun 30, 2022 -279,420.00
Mar 31, 2022 -263,718.00